Since the discovery of the Australia antigen (Blumberg et al., 1965) and its association with the hepatitis B virus (Prince, 1968; Blumberg et al., 1970) , a group of asymptomatic carriers of the antigen has been identified together with acute and chronic hepatic disease (Gocke et al., 1970; Cherubin and Prince, 1971; Berris et al., 1973; Szmunness et al., 1973 ) .
The number of these asymptomatic carriers varies from one country to another (Prince, 1970; Salzano et al., 1970) and depends on many factors such as the social behaviour of the population (Mazzur and Jones, 1977) , drug addiction (Cherubin et atl., 1970) , use of commercial blood (Alter et al., 1975) , and family clustering (Blumberg et al., 1969; Velasco et al., 1973; Szmuness et al., 1975 ) .
The prognosis of these individuals has not been defined exactly, although the literature reveals that there is some degree of abnormality on liver biopsy in the majority of asymptomatic carriers (Prince et al., 1969; Reinicke et al., 1972; Simon and Patel 1974; Shrago et al., 1977) .
In an attempt to determine the prognosis of the asymptomatic HBsAg carriers in Chile we undertook a clinical and pathological study of those individuals whose blood had been positive for HBsAg for at least four months. ' One-hundred-and-fifty donors positive for at least four months were examined and laboratory study performed. Thirty-eight of these were eligible for liver biopsy and were followed up regularly at intervals of six months. The minimum follow-up period was six months, 14 were followed up for more than 12 months, and 20 for more than 24 months.
These carriers were submitted to a complete clinical examination; liver function tests (serum bilirubin, alkaline phosphatase, SGPT, prothrombin time, bromsulphthalein retention test); serum levels of immunoglobulins (Ig G, Ig M, Ig A) and C3 by the Mancini test; alpha fetoprotein by immunodiffusion and haemagglutination.
Liver biopsies were performed in the 38 cases with a Menghini needle and studied in a paraffin- Ig G levels were slightly raised in 24, Ig M in 12, and Ig A in 30 cases. C3 was normal in 36 cases, being slightly low in the other two.
Alpha fetoprotein was present in two.
LIVER HISTOLOGY
The results of the biopsy were correlated with the liver function tests and the findings are set out in the Table. The first patient presented 12 months later with abdominal pain, rapid weight loss, and a very large nodular and rock-hard liver. Laparoscopy and liver biopsy confirmed a primary carcinoma of the liver without cirrhosis. Liver function tests showed a slight increase in serum bilirubin, alkaline phosphatase of 18 KA, and bromsulphthalein retention 20 % at 30 minutes.
The second patient developed mild diarrhoea, anorexia, weight loss, abdominal pain, a marked enlarged nodular liver, and splenomegaly after 18 months. The liver specimen showed hepatocellular carcinoma. Liver function tests were as follows: serum bilirubin of 1-8 mg per 100 ml., alkaline phosphatase of 24 KA, prothombin time of 45%, and bromsulphthalein with retention at 30 minutes; alpha fetoprotein remained positive in the two cases.
Discussion
The ultimate prognosis of the carrier state of hepatitis B virus infection remains uncertain. In our study only 10 out of 38 asymptomatic carriers had normal liver histology. In three heavy alcoholics, alcoholic cirrhosis was found. In 22 cases the lesions found were considered to be minor and in three severe.
Is the coexistence of hepatocarcinoma with the hepatitis B virus fortuitous or pathogenetically related ?
In Chile, where necropsy is mandatory in patients who die in a hospital, the incidence of hepatocarcinoma is low. However 70% of the hepatocarcinomas are HBsAg positive (Velasco et al., 1971) . The incidence of the HBsAg in the Chilean general population is 0-3% and in carrier families 14%. In a familial study of these chronic carriers we found that four out of 23 families had one or more siblings, with a confirmed hepatocarcinoma (Velasco et al., 1973) . Recently we have seen a patient with chronic aggressive hepatitis who was HBsAg positive, whose sister had a postnecrotic cirrhosis and whose mother died of primary carcinoma of the liver. In the literature, cases of familial hepatocarcinoma have been reported (Denison et al., 1971) . To our knowledge this is the first report in which a hepatocarcinoma appeared in the follow-up study of an asymptomatic HBsAg carrier. All these observations support the idea of a possible oncogenic role of the hepatitis B virus.
Investigation of alpha fetoprotein seems most important in asymptomatic chronic carriers. In our two patients in whom a hepatocarcinoma appeared the test was positive many months before the emergence of the tumour.
It has been postulated that the carrier state depends on a relative immunological defect against the hepatitis B virus (Dudley et al., 1972) . A lack of response to stimulation of lymphocytes to HBsAg has been shown in chronic carriers (Millman et al., 1971; Sutnick et al., 1973) .
It is possible that this group of asymptomatic carriers is a heterogeneous one. Some of these individuals have a mild chronic process with an ultimately good prognosis, while others progress to severe or irreversible damage.
